Abbott Laboratories (ABT) Return on Capital Employed (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Return on Capital Employed data on file, last reported at 9.61% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 81.0% year-over-year to 9.61%; the trailing twelve-month figure through Mar 2026 stood at 9.61% (down 81.0% YoY), and the FY2025 full-year result was 11.92%, up 111.0% from the prior year.
• Return on Capital Employed eased to 9.61% in Q1 2026, from 11.68% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 33.58% in Q4 2022 to a low of 9.61% in Q1 2026.
• A 5-year average of 14.93% and a median of 11.01% in 2023 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed jumped 658 bps in 2022 and tumbled 2256 bps in 2023, its largest moves.
• Tracing ABT's Return on Capital Employed over 5 years: stood at 33.58% in 2022, then plunged by 67 bps to 11.01% in 2023, then declined by 3 bps to 10.71% in 2024, then rose by 9 bps to 11.68% in 2025, then decreased by 18 bps to 9.61% in 2026.
• Business Quant data shows ABT's Return on Capital Employed at 9.61% in Q1 2026, 11.68% in Q4 2025, and 11.1% in Q3 2025.